Sort   by:  
 Page size 
0
UnknownNorms for the Triana Test: A Story Recall Test Based on Emotional Material.
Not available
S-EPMC10657724 | biostudies-literature
0
UnknownLiver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation.
Not available
S-EPMC8888708 | biostudies-literature
0
UnknownOne-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population.
Not available
S-EPMC11497651 | biostudies-literature
0
UnknownFibroblast growth factor 21 is a hepatokine involved in MASLD progression.
Not available
S-EPMC11485537 | biostudies-literature
0
UnknownGenetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease.
Not available
S-EPMC7732106 | biostudies-literature
0
UnknownPrevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology.
Not available
S-EPMC9541569 | biostudies-literature
0
UnknownThe biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis.
Not available
S-EPMC11217049 | biostudies-literature
0
UnknownCopy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease.
Not available
S-EPMC8365315 | biostudies-literature
0
UnknownMistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 Locus.
Not available
S-EPMC8188187 | biostudies-literature
0
UnknownWithdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU.
Not available
S-EPMC11874338 | biostudies-literature
Sort   by:  
 Page size